VYLOY
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for VYLOY, covering 2024-10-18 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.